Ordering Publications

To order a hard copy of any of the publications listed below from UCLA ISAP, send the article number (found at the end of the reference, for example "12.1"), the article author/title, and your postal address to:

Kris Langabeer
UCLA Integrated Substance Abuse Programs
1640 S. Sepulveda Blvd., Ste. 200
Los Angeles, CA 90025-7535

Your first 5 articles ordered per year are free, but additional articles are $1 per reprint. Checks should be made out to "UC Regents." Purchase orders will not be accepted for orders under $25.

Publications List (D-G)

(A list of all publications is available as an .rtf file).

Danila, B., Annon, J. J., & Anglin, M. D. (1997). State demand and treatment needs assessment study: Dependence and abuse of alcohol and other drugs among California arrestees. (Contract No. 270-92-0012). Los Angeles, CA: UCLA Drug Abuse Research Center. (06.33)

Dekimpe, M. G., Van de Gucht, L. M., Hanssens, D. M., & Powers, K. I. (1995). Long-run abstinence after treatment for narcotics abuse: What are the odds? Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (18.48)

Denison, M. E., Paredes, A., & Booth, J. B. (1997). Alcohol and cocaine interactions and aggressive behaviors. In: Recent Developments in Alcoholism, Vol. 13: Alcohol and Violence: Epidemiology, Neurobiology, Psychology, Family Issues (pp. 283-303). New York, NY: Plenum Press. (02.9)

Deren, S. (1988). Parenting and drug abuse: Issues and services. Los Angeles: Drug Abuse Information and Monitoring Project, UCLA Drug Abuse Research Center. (11.3)

Deschenes, E. P. (1988). Cocaine use and pregnancy. Los Angeles: Drug Abuse Information and Monitoring Project, UCLA Drug Abuse Research Center. (21.2)

Deschenes, E. P. (1990). Longitudinal research designs. In: K. L. Kempf (Ed.), Measurement issues in criminology (pp. 152-166). New York: Springer-Verlag. (12.13)

Deschenes, E. P., & Anglin, M. D. (1992). Effects of legal supervision on narcotic addict behavior, ethnic and gender influences . In: T. Mieczkowski (Ed.), Drugs, crime, and social policy (pp. 167-196). Boston: Allyn and Bacon. (06.19)

Deschenes, E. P., Anglin, M. D., & Speckart, G. R. (1991). Narcotics addiction: Related criminal careers, social and economic costs. Journal of Drug Issues, 21(2), 383-411. (06.15)

Domier, C. P., Simon, S. L., Rawson, R., Huber, A., & Ling, W. (2000). A comparison of injecting and noninjecting methamphetamine users. Journal of Psychoactive Drugs, 32(2), 229-232. (28.19)

Douglas, S. D., Camarca, M., Xu, J., Durako, S. J., Murphy, D. A., Moscicki, B., & Wilson, C. M. (2003). The relationships between substance abuse, psychosocial variables, and natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents. AIDS Research and Human Retroviruses, 19(5), 399-408. (01.92)

Doverty, M., Somogyi, A. A., White, J. M., Bochner, F., Beare, C. H., Menelaou, A., & Ling, W. (2001). Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain, 93(2), 155-163. (10.40)

Doverty, M., White, J. M., Somogyi, A. A., Bochner, F., Ali, R., & Ling, W. (2001). Hyperalgesic responses in methadone maintenance patients. Pain, 90(1-2), 91-96. (10.39)

Doverty, M., White, J. M., Somogyi, A. A., Bochner, F., Ali, R., & Ling, W. (2002). Reply to Dr. Clark's comment on Doverty et al., hyperalgesic responses in methadone maintenance patients (Pain 2001; 90; 91-96). Pain, 99(3), 609-610. (10.43)

Ebener, P., Saner, H., & Anglin, M. D. (1995). Building a data and analysis infrastructure to support substance abuse policy decisionmaking: A strategic plan. Sacramento, CA: California Department of Alcohol and Drug Programs. (13.11)

Eisen, V., Abraham, E., Burdon, W. M., & Hurdle, F. (2000). Community behind the walls: Challenges facing in-custody therapeutic communities. San Francisco, CA: Walden House, Inc. (18.71)

Ernst, M., Bolla, K., Mouratidis, M., Contoreggi, C., Matochik, J. A., Kurian, V., Cadet, J. L., Kimes, A. S., & London, E. D. (2002). Decision-making in a risk-taking task: a PET study. Neuropsychopharmacology, 26(5), 682-691. (30.10)

Ernst, M., Grant, S., London, E. D., Contoreggi, C., Kimes, A. S., & Spurgeon, L. (2003). Decision making in adolescents with behavior disorders and adults with substance abuse. American Journal of Psychiatry, 160(1), 33-40. (05.18)

Ernst, M., Heishman, S. J., Spurgeon, L., & London, E. D. (2001). Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology, 25(3), 313-319. (17.3)

Ernst, M., Kimes, A. S., London, E. D., Matochik, J. A., Eldreth, D., Tata, S., Contoreggi, C., Leff, M., & Bolla, K. (2003). Neural substrates of decision making in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry, 160(6), 1061-1070. (30.27)

Ernst, M., Matochik, J. A., Heishman, S. J., Van Horn, J. D., Jons, P. H., Henningfield, J. E., & London, E. D. (2001). Effect of nicotine on brain activation during performance of a working memory task. Proceedings of the National Academy of Sciences of the United States of America, 98(8), 4728-4733. (30.12)

Falkin, G. P., Prendergast, M. L., & Anglin, M. D. (1994). Drug treatment in the criminal justice system. Federal Probation, 58(3), 31-36. (06.12)

Falkin, G. P., Wellisch, J., Prendergast, M. L., Kilian, T. C., Hawke, J., Natarajan, M., Kowalewski, M. R., & Owen, B. (1994). Drug treatment for women offenders: A systems perspective. New York: National Development and Research Institutes, Inc.; Los Angeles: Drug Abuse Research Center. (18.34)

Farabee, D. (2002). Reexamining Martinson's critique: A cautionary note for evaluators. Crime and Delinquency, 48(1), 189-192. (03.14)

Farabee, D., Joshi, V., & Anglin, M. D. (2001). Addiction careers and criminal specialization. Crime and Delinquency, 47(2), 196-220. (06.41)

Farabee, D., & Leukefeld, C. G. (2002). HIV and AIDS prevention strategies. In: C. G. Leukefeld, D. Farabee, & F. M. Tims (Eds.), Treatment of Drug Offenders: Policies and Issues (pp. 172-185, xiv, 453). New York: Springer Publishing.(01.61)

Farabee, D., & Leukefeld, C. G. (1999). Opportunities for AIDS prevention in a rural state in criminal justice and drug treatment settings. Substance Use and Misuse, 34(4-5), 617-631. (01.51)

Farabee, D., Leukefeld, C. G., & Hays, L. (1998). Accessing drug abuse treatment: Perceptions of out-of-treatment injectors. Journal of Drug Issues, 28(2), 391-394. (18.61)

Farabee, D., Monahan, G., Hegamin, A., Gil-Rivas, V., & Kalechstein, A. (1998). Implementation of the CYA-RSAT Programs. A process evaluation of the California Youth Authority's Residential Substance Abuse Treatment (RSAT) Programs (Year 1). Sacramento, CA: Office of Criminal Justice Planning and The California Department of Youth Authority. (24.14)

Farabee, D., Prendergast, M. L., & Anglin, M. D. (1998). The effectiveness of coerced treatment for drug-abusing offenders. Federal Probation, 62(1), 3-10. (06.35)

Farabee, D., Prendergast, M. L., & Cartier, J. (2002). Alcohol, the "un-drug". Psychiatric Services, 53(11), 1375-1376. (02.17)

Farabee, D., Prendergast, M. L., & Cartier, J. (2002). Methamphetamine use and HIV risk among substance-abusing offenders in California. Journal of Psychoactive Drugs, 34(3), 295-300. (28.20)

Farabee, D., Prendergast, M. L., Cartier, J., Wexler, H., Knight, K., & Anglin, M. D. (1999). Barriers to implementing effective correctional drug treatment programs. Prison Journal, 79(2), 150-162. (06.37)

Farabee, D., Rawson, R., & McCann, M. J. (2002). Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments. Journal of Substance Abuse Treatment, 23, 343-350. (18.105)

Farabee, D., Shen, H., Hser, Y., Grella, C. E., & Anglin, M. D. (2001). The effect of drug treatment on criminal behavior among adolescents in DATOS-A. Journal of Adolescent Research, 16(6), 679-696. (06.24)

Farabee, D., Shen, H., & Sanchez, S. (2002). Perceived coercion and treatment need among mentally ill parolees. Criminal Justice and Behavior, 29(1), 76-86. (03.15)

Farrell, M., Marsden, J., & Ling, W. (2002). Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction, 97, 771-772. (28.18)

Finnerty, B. A. (2003). Monitoring and reporting alcohol and drug use trends in California: The California Substance Abuse Research Consortium Meetings. Journal of Psychoactive Drugs, SARC Supplement 1, 119-125. (08.10)

Fiorentine, R. (1999). After drug treatment: are 12-step programs effective in maintaining abstinence? American Journal of Drug and Alcohol Abuse, 25(1), 93-116. (18.82)

Fiorentine, R. (1994). Assessing drug and alcohol treatment needs of general and special populations: Conceptual, empirical and inferential issues. Journal of Drug Issues, 24(3), 445-462. (18.29)

Fiorentine, R. (1993). Beyond equity in the delivery of alcohol and drug abuse treatment services. Journal of Drug Issues, 23(4), 559-577. (18.28)

Fiorentine, R. (2001). Counseling frequency and the effectiveness of outpatient drug treatment: revisiting the conclusion that "more is better". American Journal of Drug and Alcohol Abuse, 27(4), 617-631. (18.97)

Fiorentine, R. (1998). Effective drug treatment: Testing the distal needs hypothesis. Journal of Substance Abuse Treatment, 15(4), 281-289. (18.63)

Fiorentine, R., & Anglin, M. D. (1997). Does increasing the opportunity for counseling increase the effectiveness of outpatient drug treatment? American Journal of Drug and Alcohol Abuse, 23(3), 369-382. (18.47)

Fiorentine, R., & Anglin, M. D. (1996). More is better: Counseling participation and the effectiveness of outpatient drug treatment. Journal of Substance Abuse Treatment, 13(4), 341-348. (18.50)

Fiorentine, R., & Anglin, M. D. (1994). Perceiving need for drug treatment: A look at eight hypotheses. International Journal of the Addictions, 29(14), 1835-1854. (18.30)

Fiorentine, R., Anglin, M. D., Gil-Rivas, V., & Taylor, E. (1997). Drug treatment: Explaining the gender paradox. Substance Use And Misuse, 32(6), 653-678. (18.75)

Fiorentine, R., & Hillhouse, M. P. (2001). The addicted-self model: an explanation of "natural" recovery? Journal of Drug Issues, 31(2), 395-415,417-423. (18.58)

Fiorentine, R., & Hillhouse, M. P. (2000). Drug treatment and 12-step program participation: the additive effects of integrated recovery activities. Journal of Substance Abuse Treatment, 18(1), 65-74. (18.88)

Fiorentine, R., & Hillhouse, M. P. (1999). Drug treatment effectiveness and client-counselor empathy: Exploring the effects of gender and ethnic congruency. Journal of Drug Issues, 29(1), 59-74. (18.84)

Fiorentine, R., & Hillhouse, M. P. (2000). Exploring the additive effects of drug misuse treatment and twelve-step involvement: Does twelve-step ideology matter? Substance Use and Misuse, 35(3), 367-397. (18.86)

Fiorentine, R., & Hillhouse, M. P. (2003). Replicating the addicted-self model of recovery. Addictive Behaviors, 28, 1063-1080. (18.108)

Fiorentine, R., & Hillhouse, M. P. (2000). Self-efficacy, expectancies, and abstinence acceptance: further evidence for the addicted-self model of cessation of alcohol- and drug-dependent behavior. American Journal of Drug and Alcohol Abuse, 26(4), 497-521. (18.67)

Fiorentine, R., Hillhouse, M. P., & Anglin, M. D. (2002). Drug-use careers. In: C. G. Leukefeld, F. M. Tims, & D. Farabee (Eds.), Treatment of Drug Offenders: Policies and Issues (pp. 273-282, xiv, 453). New York: Springer Publishing Co. (06.42)

Fiorentine, R., Hser, Y., & Anglin, M. D. (1997). "Dabblers," "dealers," "stealers," and "stealer-dealers": Criminal specialization among male narcotic users. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (06.27)

Fiorentine, R., Nakashima, J. D., & Anglin, M. D. (1999). Client engagement in drug treatment. Journal of Substance Abuse Treatment, 17(3), 199-206. (18.83)

Fiorentine, R., Pilati, M. L., & Hillhouse, M. P. (1999). Drug treatment outcomes: investigating the long-term effects of sexual and physical abuse histories. Journal of Psychoactive Drugs, 31(4), 363-372. (18.85)

Fisher, D. G., & Anglin, M. D. (1987). Survival analysis in drug program evaluation. Part I. Overall program effectiveness. International Journal of the Addictions, 22(2), 115-134. (16.2)

Fisher, D. G., Anglin, M. D., Weisman, C. P., & Pulliam, L. (1989). Replication problems of substance abuser MMPI cluster types. Multivariate Behavioral Research, 24(3), 335-352. (12.2)

Fisher, D. G., MacKinnon, D. P., Anglin, M. D., & Thompson, J. P. (1987). Parental influences on substance use: Gender differences and stage theory. Journal of Drug Education, 17(1), 69-86. (11.2)

Fletcher, B. W., & Grella, C. E. (2001). Preface to the JAR special issue: The Drug Abuse Treatment Outcome Studies for Adolescents. Journal of Adolescent Research, 16(6), 537-544. (05.8)

Freese, T. E., Miotto, K., & Reback, C. J. (2002). The effects and consequences of selected club drugs. Journal of Substance Abuse Treatment, 23(2), 151-156. (05.17)

Frosch, D. L., Nahom, D., & Shoptaw, S. (2002). Optimizing smoking cessation outcomes among the methadone maintained. Journal of Substance Abuse Treatment, 23, 425-430. (17.9)

Frosch, D. L., Shoptaw, S., Huber, A., Rawson, R., & Ling, W. (1996). Sexual HIV risk among gay and bisexual male methamphetamine abusers. Journal of Substance Abuse Treatment, 13(6), 483-486. (28.4)

Frosch, D. L., Shoptaw, S., Jarvik, M. E., Rawson, R., & Ling, W. (1998). Interest in smoking cessation among methadone maintained outpatients. Journal of Addictive Diseases, 17(2), 9-19. (10.33)

Frosch, D. L., Shoptaw, S., Nahom, D., & Jarvik, M. E. (2000). Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals. Experimental and Clinical Psychopharmacology, 8(1), 97-103. (10.35)

Fudala, P. J., Bridge, P., Herbert, S., Williford, W. O., Chiang, N., Jones, K., Collins, H., Raisch, D., Casadonte, P., Goldsmith, R. J., Ling, W., Malkerneker, U., McNicholas, L., Renner, J., Stine, S., & Tusel, D. (2003). Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine, 349(10), 949-954. (29.27)

Galaif, E. R., Hser, Y., Grella, C. E., & Joshi, V. (2001). Prospective risk factors and treatment outcomes among adolescents in DATOS-A. Journal of Adolescent Research, 16(6), 661-678. (05.9)

Gawin, F. H., Khalsa, M. E., Carroll, K., Kosten, T. R., & Jatlow, P. (1992). Cocaine abstinence is predicted by desipramine hydrochloride plasma concentrations. Paper presented at the Proceedings of the 54th annual scientific meeting, the College on Problems of Drug Dependence, Inc., Keystone, Colorado. (04.21)

Gawin, F. H., Khalsa, M. E., & Ellinwood, E. (1995). Stimulants. In: G. Gabbard, & H. Kleber (Eds.), Treatment of psychiatric disorders: The DSM-IV edition (pp. 706-720). Washington, DC: American Psychiatric Association Press. (04.17)

Gil-Rivas, V., & Anglin, M. D. (1998). Patterns of substance use and characteristics of Latino juvenile arrestees: Prevention, treatment, and policy implications. Final report, August 17, 1998. (09.14)

Gil-Rivas, V., Anglin, M. D., & Annon, J. J. (1997). Patterns of drug use and criminal activities among Latino arrestees in California: Treatment and policy implications. Journal of Psychopathology and Behavioral Assessment, 19(2), 161-174. (09.21)

Gil-Rivas, V., Fiorentine, R., & Anglin, M. D. (1996). Sexual abuse, physical abuse, and posttraumatic stress disorder among women participating in outpatient drug abuse treatment. Journal of Psychoactive Drugs, 28(1), 95-102. (21.19)

Gil-Rivas, V., Fiorentine, R., Anglin, M. D., & Taylor, E. (1997). Sexual and physical abuse: Do they compromise drug treatment outcomes? Journal of Substance Abuse Treatment, 14(4), 351-358. (18.59)

Goldstein, H. M. (1989). The availability of methadone maintenance in California. Los Angeles: Drug Abuse Information and Monitoring Project, UCLA Drug Abuse Research Center. (10.9)

Goldstein, H. M. (1991). The effectiveness of methadone maintenance treatment. Los Angeles: Drug Abuse Information and Monitoring Project, UCLA Drug Abuse Research Center. (10.12)

Grant, S., Contoreggi, C., & London, E. D. (2000). Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia, 38(8), 1180-1187. (13.27)

Greene, S., Haney, C., & Hurtado, A. (2000). Cycles of pain: Risk factors in the lives of incarcerated mothers and their children. Prison Journal, 80(1), 3-23. (21.26)

Greenwell, L., & Brecht, M. L. (2003). Self-reported health status among treated methamphetamine users. American Journal of Drug and Alcohol Abuse, 29(1), 75-104. (28.23)

Grella, C. E. (1996). Background and overview of mental health and substance abuse treatment systems: Meeting the needs of women who are pregnant or parenting. Journal of Psychoactive Drugs, 28(4), 319-343. (21.17)

Grella, C. E. (1994). Contrasting a shelter and day center for homeless mentally ill women: Four patterns of service use. Community Mental Health Journal, 30(1), 3-16. (15.3)

Grella, C. E. (2003). Contrasting the views of substance misuse and mental health treatment providers on treating the dually diagnosed. Substance Use and Misuse, 38(10), 1433-1446. (15.17)

Grella, C. E. (2003). Effects of gender and diagnosis on addiction history, treatment utilization, and psychological functioning among a dually-diagnosed sample in drug treatment. Journal of Psychoactive Drugs, SARC Supplement 1, 169-179. (15.16)

Grella, C. E. (1993). A residential recovery program for homeless alcoholics: Differences in program recruitment and retention. Special section: Alcohol and drug abuse services for homeless populations. Journal of Mental Health Administration, 20(2), 90-99. (02.8)

Grella, C. E. (1997). Services for perinatal women with substance abuse and mental health disorders: The unmet need. Journal of Psychoactive Drugs, 29(1), 67-78. (21.25)

Grella, C. E. (1999). Women in residential drug treatment: Differences by program type and pregnancy. Journal of Health Care for the Poor and Underserved, 10(2), 216-229. (21.22)

Grella, C. E., & Anglin, M. D. (1994). Implementing an enhanced methadone maintenance program for HIV risk reduction in Los Angeles. In: B. W. Fletcher, J. A. Inciardi, & A. M. Horton (Eds.), Drug abuse treatment: The implementation of innovative approaches (pp. 3-18). Westport, CT: Greenwood Press. (10.16)

Grella, C. E., Anglin, M. D., & Annon J. J. (1996). HIV risk behaviors among women in methadone maintenance treatment. Substance Use and Misuse, 31(3), 277-301. (10.24)

Grella, C. E., Anglin, M. D., Rawson, R., Crowley, R., & Hasson, A. (1996). What happens when a demonstration project ends. Consequences for a clinic and its clients. Journal of Substance Abuse Treatment, 13(3), 249-256. (10.26)

Grella, C. E., Anglin, M. D., & Wugalter, S. E. (1995). Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients. Drug and Alcohol Dependence, 37(1), 15-21. (10.22)

Grella, C. E., Anglin, M. D., & Wugalter, S. E. (1997). Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment. American Journal of Drug and Alcohol Abuse, 23(1), 15-42. (10.28)

Grella, C. E., Anglin, M. D., Wugalter, S. E., & Annon, J. J. (1997). The effectiveness of the Los Angeles enhanced methadone maintenance project: Reducing HIV risk among injection drug users. In: F. M. Tims, J. A. Inciardi, B. W. Fletcher, & A. M. Horton (Eds.), The effectiveness of innovative approaches in the treatment of drug abuse (pp. 17-32). Westport, CT: Greenwood Press. (10.29)

Grella, C. E., Anglin, M. D., Wugalter, S. E., Rawson, R., & Hasson, A. (1994). Reasons for discharge from methadone maintenance for addicts at high risk of HIV infection or transmission. Journal of Psychoactive Drugs, 26(2), 223-232. (10.20)

Grella, C. E., Annon, J. J., & Anglin, M. D. (2000). Drug use and risk for HIV among women arrestees in California. AIDS and Behavior, 4(3), 289-295. (01.48)

Grella, C. E., Annon, J. J., & Anglin, M. D. (1995). Ethnic differences in HIV risk behaviors, self-perceptions, and treatment outcomes among women in methadone maintenance treatment. Journal of Psychoactive Drugs, 27(4), 421-433. (09.11)

Grella, C. E., Campos, M., & Anglin, M. D. (1998). Relationship of HIV testing and high-risk behaviors among clients in methadone maintenance treatment. AIDS Education and Prevention, 10(5), 403-416. (10.27)

Grella, C. E., Chaiken, S., & Anglin, M. D. (1995). A procedure for assessing the validity of self-report on data on high-risk sex behaviors from heroin addicts entering free methadone treatment. Journal of Drug Issues, 25(4), 723-733. (10.19)

Grella, C. E., Etheridge, R. M., Joshi, V., & Anglin, M. D. (2000). Delivery of HIV risk-reduction services in drug treatment programs. Journal of Substance Abuse Treatment, 19(3), 229-237. (01.23)

Grella, C. E., & Gilmore, J. (2002). Improving service delivery to the dually diagnosed in Los Angeles County. Journal of Substance Abuse Treatment, 23, 115-122. (15.14)

Grella, C. E., & Hser, Y. (1997). A county survey of mental health services in drug treatment programs. Psychiatric Services, 48(7), 950-952. (15.5)

Grella, C. E., Hser, Y., Joshi, V., & Anglin, M. D. (1999). Patient histories, retention and outcome models for younger and older adults in DATOS. Drug and Alcohol Dependence, 57(2), 151-166. (18.81)

Grella, C. E., Hser, Y., Joshi, V., & Rounds-Bryant, J. (2001). Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. Journal of Nervous and Mental Disease, 189(6), 384-392. (05.12)

Grella, C. E., & Joshi, V. (1999). Gender differences in drug treatment careers among clients in the National Drug Abuse Treatment Outcome Study. American Journal of Drug and Alcohol Abuse, 25(3), 383-404. (14.7)

Grella, C. E., & Joshi, V. (2003). Treatment processes and outcomes among adolescents with a history of abuse who are in drug treatment. Child Maltreatment, 8(1), 7-18. (05.20)

Grella C.E., Joshi, V., & Anglin, M. D. (2003). Gender differences and treatment outcomes among methadone patients in the Drug Abuse Treatment Outcome Study. Journal of Maintenance in the Addictions, 2(1/2), 103-128. (10.42)

Grella, C. E., Joshi, V., & Hser, Y. (2000). Program variation in treatment outcomes among women in residential drug treatment. Evaluation Review, 24(4), 364-383. (21.29)

Grella, C. E., Perry, S. M., & Anglin, M. D. (1996). Drug and alcohol treatment programs for women: Client characteristics, program characteristics, and treatment outcomes. Rockville, MD: Center for Substance Abuse Treatment, National Evaluation Data and Technical Assistance Center. (21.18)

Grella, C. E., Polinsky, M. L., Hser, Y., & Perry, S. M. (1999). Characteristics of women-only and mixed-gender drug abuse treatment programs. Journal of Substance Abuse Treatment, 17(1-2), 37-44. (18.77)

Grella, C.E., Scott, C.K., Foss, M.A., Joshi, V., & Hser, Y.I. (2003). Gender differences in drug treatment outcomes among participants in the Chicago Target Cities Study. Evaluation and Program Planning, 26(3), 297-310. (14.16)

Grella, C. E., Wugalter, S. E., & Anglin, M. D. (1997). Predictors of treatment retention in enhanced and standard methadone maintenance treatment for HIV risk reduction. Journal of Drug Issues, 27(2), 203-224. (10.31)

Gresenz, C. R., Watkins, K. E., & Podus, D. (1998). Supplemental Security Income (SSI), Disability Insurance (DI), and substance abusers. Community Mental Health Journal, 34(4), 337-350. (26.05)

Gresenz, C. R., Watkins, K. E., & Podus, D. (1997). Supplemental security income (SSI), disability insurance (DI), substance abusers: The impact of benefit termination. Los Angeles: University of California, Los Angeles and RAND. (20.12)

Gresenz, C. R., Watkins, K. E., Podus, D., & Anglin, M. D. (1997). Benefits for substance abusers repealed: Impact in California (Policy Brief). Los Angeles: UCLA Center for Health Policy Research. (13.13)

Grills, C., & Longshore, D. (1996). Africentrism: Psychometric analyses of a self-report measure. Journal of Black Psychology, 22(1), 86-106. (09.8)

Last updated - 02/11/2010

Top of Page